Proteon Pharmaceuticals is delighted to announce that the Ministry of Agriculture, Livestock Farming and Supplies (MAPA) in Brazil has registered BAFASAL PRO, our latest bacteriophage-based feed additive. BAFASAL PRO harnesses the power of natural bacteriophage technology to improve animal health and production efficiency.
As our CEO highlighted, this registration underscores our commitment to providing effective and natural solutions to address global food production challenges. Brazil, the world’s second-largest producer of chicken meat, represents a significant milestone in our efforts to broaden access to bacteriophage technology on a global scale1.
“The successful registration of BAFASAL PRO marks our third product approval in Brazil and the second in 2024, validating our strategic approach and the market’s confidence in our solutions. This continued expansion of our product portfolio in one of the world’s leading agricultural markets reflects the increasing demand for our innovative technologies. This expansion confirms our commitment to advancing global healthcare solutions and our dedication to growth in international markets.” – Professor Jarosław Dastych, Founder & CEO of Proteon Pharmaceuticals.
BAFASAL PRO is a liquid feed additive consisting of four virulent bacteriophages. The product helps prevent Salmonella infection in the gastrointestinal tract of poultry. This solution helps maintain intestinal balance with no negative impact on the microbiome consequently improving performance parameters in birds.
“The registration process advanced smoothly, and we are pleased to announce that BAFASAL PRO has been successfully registered by Brazil’s Ministry of Agriculture, Livestock Farming and Supplies as a zootechnical feed additive for anti-Salmonella applications. We have demonstrated the product’s safety and efficacy through comprehensive documentation delivered by our R&D team, meeting all regulatory requirements.” – Małgorzata Stańczyk, PhD, Chief Registration & IP Officer in Proteon Pharmaceuticals.
In 2024, Proteon has achieved two product registrations in Brazil. In August, MAPA approved BAFACOL B – the liquid feed additive consisting of five virulent bacteriophages that is designed to protect poultry flocks from colibacillosis caused by Avian Pathogenic E. coli (APEC). The product supports the prevention of high mortality and productivity losses with no negative impact on the microbiome, hence improving growth, productivity, and performance.
Proteon Pharmaceuticals looks forward to collaborating with partners in Brazil to bring innovative solutions to livestock farming and contribute to a healthier, more sustainable future.
Sources
- Brazil chicken production estimated to increase in 2024, The Poultry Site: Available Here
